Dermatology, Procedural Dermatology · Pikeville, KY
NPI
1669426003
Since 2006
Specialty
Dermatology, Procedural Dermatology
Code 207NS0135X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
108 N Auxier Ave
Pikeville, KY, 41501
Phone (606) 432-9106
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
38,897 services
Medicare patients, 2024
571
Average age 74
Drug cost, 2024
$840K
1,424 prescriptions
Company payments, 2025
$1,714
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy R Lavender was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 34,801 times for 72 patients. In total Timothy R Lavender billed 38,897 services in 57 codes, and Medicare paid $288K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 34,801 | 72 | $1.21 | $42K |
| 17003 Destruction Skin Lesion | Office | 1,362 | 241 | $4.83 | $6,582 |
| 99213 Office E&M - Established | Office | 621 | 415 | $59.78 | $37K |
| 17004 Destruction Skin Lesion | Office | 550 | 373 | $120.02 | $66K |
| 17000 Destruction Skin Lesion | Office | 359 | 275 | $39.88 | $14K |
| 99214 Office E&M - Established | Office | 264 | 215 | $93.44 | $25K |
| 11102 Skin Biopsy | Office | 258 | 212 | $67.11 | $17K |
| 96574 Skin | Office | 175 | 72 | $206.20 | $36K |
| 99202 Office E&M - New | Office | 61 | 61 | $49.16 | $2,998 |
| 11103 Skin Biopsy | Office | 60 | 48 | $34.76 | $2,086 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 52 | 13 | $0.70 | $36.33 |
| 17111 Destruction Skin Lesion | Office | 35 | 23 | $99.62 | $3,487 |
| 10040 Removal or Shaving of Skin Growth | Office | 32 | 31 | $84.29 | $2,697 |
| 17262 Destruction Skin Lesion | Office | 21 | 20 | $131.37 | $2,759 |
| 99212 Office E&M - Established | Office | 20 | 18 | $42.92 | $858 |
By year: 2022 $263K for 33,558 services; 2023 $230K for 29,570 services; 2024 $288K for 38,897 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy R Lavender prescribed most often to Medicare patients was Mometasone Furoate, with 241 prescriptions and refills. In total Timothy R Lavender wrote 1,424 Medicare prescriptions that cost $840K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mometasone Furoate Generic | 241 | 253 | 131 | $4,998 |
| Azithromycin Generic | 161 | 161 | 130 | $657 |
| Alclometasone Dipropionate Generic | 97 | 111 | 80 | $5,651 |
| Famciclovir Generic | 90 | 97 | 25 | $3,487 |
| Clobetasol Propionate Generic | 83 | 119 | 46 | $3,733 |
| Minocycline Hcl Generic | 73 | 81 | 49 | $1,097 |
| Dupixent Syringe Dupilumab | 72 | 72 | Under 11 | $272K |
| Mupirocin Generic | 61 | 61 | 43 | $363 |
| Cephalexin Generic | 43 | 43 | 36 | $115 |
| Ciclopirox Generic | 41 | 62 | 20 | $2,757 |
| Fluconazole Generic | 39 | 39 | 35 | $364 |
| Metronidazole Generic | 34 | 38 | 18 | $1,629 |
| Terbinafine Hcl Generic | 33 | 33 | 19 | $261 |
| Hydroxychloroquine Sulfate Generic | 32 | 41 | Under 11 | $382 |
| Desonide Generic | 29 | 35 | 12 | $4,383 |
Brand drugs: 144 claims; generic drugs: 1,280 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy R Lavender $1,714 ($1,714 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $349.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 22 | $349 |
| Janssen Biotech, Inc. JNJ | 11 | $344 |
| UCB, Inc. UCB.BR | 16 | $286 |
| Genzyme Corporation SNY | 10 | $281 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 9 | $195 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $58.79 |
| LEO Pharma Inc. | 3 | $51.73 |
| Organon LLC OGN | 4 | $47.57 |
| Biofrontera Inc. | 2 | $41.31 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $37.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.